Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
AMPH
AMPH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AMPH News
Amendment to Contract Research Agreement Signed Between Amphastar Pharmaceuticals and Nanjing Hanxin Pharmaceutical Technology on March 3
3d ago
moomoo
Flutter Entertainment Reports Disappointing Q4 Results, Shares Plunge
Feb 27 2026
Benzinga
Applied Optoelectronics Reports Strong Q4, Shares Surge
Feb 27 2026
Benzinga
Amphastar Pharmaceuticals Q4 2025 Earnings Call Insights
Feb 27 2026
seekingalpha
Amphastar Pharmaceuticals Receives FDA Approval for New Drug
Feb 24 2026
Newsfilter
Amphastar Pharmaceuticals to Release Q4 2025 Results on February 26, 2026
Feb 20 2026
Newsfilter
Amphastar's Floyd Petersen Sells 16,679 Shares for $441,836
Dec 23 2025
Fool
Weekly Update: CYTK Receives Initial FDA Approval, INSM Concludes Rhinosinusitis Research, XOMA Purchases GBIO
Dec 20 2025
NASDAQ.COM
ETFs on the Move This Monday: IHE, BLOK
Dec 15 2025
NASDAQ.COM
Amphastar Pharmaceuticals Receives FDA Approval for Teriparatide Injection Device
Dec 15 2025
Newsfilter
Amphastar announces FDA approval for teriparatide injection.
Dec 15 2025
SeekingAlpha
CRMD Surges Over 40% Year-to-Date: Should You Buy, Sell, or Hold?
Dec 11 2025
NASDAQ.COM
Amphista Unveils AMX-883, Paving New Treatment Path for Acute Myeloid Leukaemia
Dec 08 2025
Globenewswire
Amphastar (AMPH) Third Quarter 2025 Earnings Call Summary
Nov 28 2025
NASDAQ.COM
Breaking Down the Components: IJR Aims for $140
Nov 11 2025
NASDAQ.COM
Daily Upgrade Report for Validea's Peter Lynch Strategy - November 11, 2025
Nov 11 2025
NASDAQ.COM
Show More News
